Voice changes in Parkinson's disease: What are they telling us?
A Ma, KK Lau, D Thyagarajan - Journal of Clinical Neuroscience, 2020 - Elsevier
Emerging evidence suggests voice dysfunction is the earliest sign of motor impairment in
Parkinson's disease (PD). The complexity and fine motor control involved in vocalization …
Parkinson's disease (PD). The complexity and fine motor control involved in vocalization …
Medications and adverse voice effects
K Nemr, ADC Silva, D de Albuquerque Rodrigues… - Journal of Voice, 2018 - Elsevier
Objectives To identify the medications used by patients with dysphonia, describe the voice
symptoms reported on initial speech-language pathology (SLP) examination, evaluate the …
symptoms reported on initial speech-language pathology (SLP) examination, evaluate the …
Levodopa-based changes on vocalic speech movements during prosodic prominence marking
The present study investigates speech changes in Parkinson's disease on the acoustic and
articulatory level with respect to prosodic prominence marking. To display movements of the …
articulatory level with respect to prosodic prominence marking. To display movements of the …
Clinical characteristics and electrophysiological biomarkers of Parkinson's disease developed from essential tremor
X Wang, Z Cao, G Liu, Z Liu, Y Jiang, H Ma… - Frontiers in …, 2020 - frontiersin.org
Background and Objective: Parkinson's disease developed from essential tremor (ET-PD) is
a distinct clinical syndrome that is different from essential tremor (ET) and Parkinson's …
a distinct clinical syndrome that is different from essential tremor (ET) and Parkinson's …
[PDF][PDF] Synergic Effect of Cu/TiO Nanocomposite, 2-(ferrocenylethynyl) fluoren-9-one and Room Temperature Ionic Liquid for the Fabrication of Highly Sensitive …
Levodopa, one of the prescribed medications in Parkinson disease, is electrochemically
determined here. A Cu/TiO2 nanocomposite/room temperature ionic liquid/2 …
determined here. A Cu/TiO2 nanocomposite/room temperature ionic liquid/2 …